CTKB
HealthcareCytek Biosciences, Inc.
$5.21
+$0.29 (+5.89%)
Jan 5, 2026
Price History (1Y)
Analysis
Cytek Biosciences, Inc. is a healthcare company that operates in the medical devices industry. With a market capitalization of $666.18 million, the company has a significant presence in its sector. It employs approximately 692 people and generates revenue of $196.83 million (TTM). The company's financial health is mixed. Its gross margin stands at 53.5%, indicating relatively high profitability on sales. However, its operating margin and profit margin are negative, suggesting that the company incurs significant expenses or faces challenges in generating earnings. The company has a debt-to-equity ratio of 6.56 and $24.83 million in debt compared to $261.73 million in cash. Returns on equity and assets are also negative at -3.4% and -4.4%, respectively. The company's valuation context is notable, with a price-to-book ratio of 1.76 and a price-to-sales ratio of 3.38. The forward P/E ratio is -347.33, which may be due to the company's recent earnings performance. Revenue growth has been relatively stable at 1.5% (YoY), but earnings growth is not available.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Cytek Biosciences, Inc.
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. The company offers aurora and northern lights systems delivers cell analysis; aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; enhanced small particle detection; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. It also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments. In addition, the company offers automated micro-sampling system and automated sample loader system, an automated loaders designed to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. It serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. The company distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in Europe, Latin America, and the Middle East countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.
Visit website →Key Statistics
- Market Cap
- $666.18M
- P/E Ratio
- N/A
- 52-Week High
- $7.30
- 52-Week Low
- $2.37
- Avg Volume
- 1.23M
- Beta
- 1.30
Company Info
- Industry
- Medical Devices
- Exchange
- NMS
- Country
- United States
- Employees
- 692